海特生物
(300683)
| 流通市值：28.50亿 | | | 总市值：30.56亿 |
| 流通股本：1.22亿 | | | 总股本：1.31亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 160,772,770.92 | 419,151,366.14 | 495,054,826.68 | 383,923,639.28 |
| 应收票据及应收账款 | 63,228,603.91 | 68,453,418.82 | 53,370,045.81 | 53,790,455.93 |
| 其中：应收票据 | 6,190,829.27 | 6,309,648.22 | 1,901,283.95 | 4,237,088.79 |
| 应收账款 | 57,037,774.64 | 62,143,770.6 | 51,468,761.86 | 49,553,367.14 |
| 应收款项融资 | 12,190,468.12 | 12,452,728.1 | 5,220,863.04 | 8,168,138.3 |
| 预付款项 | 6,703,563.22 | 4,438,544.48 | 13,034,820.02 | 18,009,524.36 |
| 其他应收款合计 | 4,169,537.69 | 6,829,757.8 | 4,416,598.06 | 5,739,509.09 |
| 存货 | 109,919,566.93 | 108,980,649.25 | 120,565,231.82 | 122,793,375.35 |
| 合同资产 | 225,771,502.13 | 219,870,434.73 | 224,296,247.81 | 203,847,220.17 |
| 其他流动资产 | 22,648,066.19 | 16,467,374.99 | 22,294,112.71 | 23,017,270.03 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,198,932,206.75 | 1,306,333,167.96 | 1,320,771,206.51 | 1,323,790,562.06 |
| 非流动资产: | | | | |
| 长期股权投资 | 11,279,057.69 | 11,582,138.28 | 20,387,529 | 21,158,146.69 |
| 其他权益工具投资 | 5,000,000 | 5,000,000 | 5,000,000 | 5,000,000 |
| 投资性房地产 | - | - | 301,747.94 | 307,822.94 |
| 固定资产 | 698,150,787.02 | 709,847,028.25 | 697,807,243.44 | 710,306,082.16 |
| 在建工程 | 15,519,177.33 | 11,020,161.84 | 1,405,063.77 | 253,197.14 |
| 使用权资产 | 7,882,022.05 | 8,819,170.87 | 10,572,891.95 | 11,672,530.88 |
| 无形资产 | 247,748,434.3 | 253,439,949.72 | 259,153,202.03 | 265,561,998.9 |
| 开发支出 | 25,308,863.82 | 25,803,143.43 | 25,401,912.88 | 23,188,355.13 |
| 商誉 | 263,591,202.15 | 263,591,202.15 | 263,591,202.15 | 263,591,202.15 |
| 长期待摊费用 | 7,869,290 | 8,683,643.93 | 9,434,299.99 | 10,669,091.81 |
| 递延所得税资产 | 121,841,045.15 | 119,939,306.37 | 118,275,130.37 | 114,508,140.29 |
| 其他非流动资产 | 217,943,350.83 | 212,574,612.61 | 211,562,543.15 | 214,389,171.47 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,622,133,230.34 | 1,630,300,357.45 | 1,622,892,766.67 | 1,640,605,739.56 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,821,065,437.09 | 2,936,633,525.41 | 2,943,663,973.18 | 2,964,396,301.62 |
| 流动负债: | | | | |
| 短期借款 | 7,208,291.01 | 7,218,533.77 | 7,247,705.02 | 7,367,605.55 |
| 交易性金融负债 | 1,000,000 | 1,000,000 | 1,000,000 | - |
| 应付票据及应付账款 | 59,046,361.84 | 64,351,724.31 | 35,929,923.43 | 37,903,063.01 |
| 应付账款 | 59,046,361.84 | 64,351,724.31 | 35,929,923.43 | 37,903,063.01 |
| 合同负债 | 63,992,671.17 | 77,544,945.62 | 101,694,719.92 | 113,156,879.88 |
| 应付职工薪酬 | 15,579,631.64 | 40,994,817.5 | 26,016,459.95 | 15,874,010.21 |
| 应交税费 | 5,089,107.59 | 7,204,933.89 | 5,312,442.1 | 5,060,751.1 |
| 其他应付款合计 | 86,532,819.27 | 138,092,212.79 | 122,504,440.28 | 115,167,959.76 |
| 应付股利 | - | 17,016,270.83 | - | - |
| 一年内到期的非流动负债 | 10,120,869.63 | 22,404,679.01 | 22,751,236.99 | 23,316,594.89 |
| 其他流动负债 | 3,224,191.15 | 4,449,051.86 | 5,145,851.03 | 5,694,748.68 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 251,793,943.3 | 363,260,898.75 | 327,602,778.72 | 323,541,613.08 |
| 非流动负债: | | | | |
| 长期借款 | 20,797,148.36 | 11,516,932.91 | 15,366,932.91 | 19,016,932.91 |
| 租赁负债 | 4,633,264.3 | 5,361,639.55 | 6,774,410.2 | 8,019,913.57 |
| 长期应付款 | 45,915,572.75 | 45,915,572.75 | 45,915,572.75 | 45,915,572.75 |
| 递延收益 | 86,250,635.12 | 84,253,596.01 | 79,206,294.85 | 80,442,419.81 |
| 递延所得税负债 | 14,505,528.44 | 14,737,685.91 | 15,267,053.78 | 16,239,865.73 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 172,102,148.97 | 161,785,427.13 | 162,530,264.49 | 169,634,704.77 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 423,896,092.27 | 525,046,325.88 | 490,133,043.21 | 493,176,317.85 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 130,894,391 | 130,894,391 | 130,894,391 | 130,894,391 |
| 资本公积 | 1,836,919,613.31 | 1,836,919,613.31 | 1,837,127,833.33 | 1,837,058,599.28 |
| 盈余公积 | 53,879,686.43 | 53,879,686.43 | 53,264,178.83 | 53,264,178.83 |
| 未分配利润 | 356,166,280.42 | 370,096,650.61 | 417,333,520.02 | 434,311,510.19 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 2,377,859,971.16 | 2,391,790,341.35 | 2,438,619,923.18 | 2,455,528,679.3 |
| 少数股东权益 | 19,309,373.66 | 19,796,858.18 | 14,911,006.79 | 15,691,304.47 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 2,397,169,344.82 | 2,411,587,199.53 | 2,453,530,929.97 | 2,471,219,983.77 |
| 负债和股东权益合计 | 2,821,065,437.09 | 2,936,633,525.41 | 2,943,663,973.18 | 2,964,396,301.62 |
| 公告日期 | 2025-04-21 | 2025-04-21 | 2024-10-23 | 2024-08-27 |
| 审计意见(境内) | | 标准无保留意见 | | |